Lorazepam: Clinical Trials

20 trials of Lorazepam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 terminated, 1 active not recruiting, 1 not yet recruiting. 20 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 320Completed 11, Terminated 4, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 25Completed 2, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial to Assess the Efficacy and Safety During Convective Radiofrequency Water Vapor Thermal Therapy (REZUM) for Benign Prostate Hyperplasia
Methoxyflurane - Penthrox, Control, Percocet Pill - Benign Prostate Hypertrophy(BPH)
Phase 3Not yet recruitingUniversity of Manitoba482025-08-012025-06-12
Acute Agitation in Emergency Psychiatry
Sublingual Dexmedetomidine, Buccal midazolam, Oral lorazepam - Agitation
Phase 2 / Phase 3RecruitingLone Baandrup1322024-12-302025-01-01
Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult
Dexmedetomidine, Lorazepam, Haloperidol - Altered Mental Status
Phase 3UnknownState University of New York - Upstate Medical University602024-06-012024-04-22
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center1102019-07-172026-06-15
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
Lorazepam - Status Epilepticus
Phase 3CompletedPfizer262014-11-012019-02-18
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Clobazam, Clonazepam, Lorazepam - Epilepsia Partialis Continua, Kojewnikov's Epilepsy
Phase 3TerminatedThe Cooper Health System72014-07-012018-05-09
Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly
etifoxine, lorazepam, Placebo - Healthy Volunteers
Phase 3CompletedBiocodex312013-12-012016-07-27
Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus
Clonazepam, Fosphenytoin, Placebo - Status Epilepticus, Epilepsy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris4342013-06-262018-10-11
Promethazine vs. Lorazepam for Treatment of Vertigo
Promethazine, Lorazepam - Peripheral Vertigo.
Phase 3CompletedShahid Beheshti University of Medical Sciences2102013-04-012013-06-14
Sedative Premedication: Efficacy On Patient Experience
Lorazepam, no premedication, Placebo (microcrystalline celluloses) - Perioperative Anxiety
Phase 3CompletedAssistance Publique Hopitaux De Marseille12002012-11-012015-04-21
Stanford Accelerated Recovery Trial (START)
Gabapentin, Lorazepam (active control), Placebo (inactive) - Pain, Breast Cancer
Phase 3TerminatedStanford University4222010-05-012022-05-05
Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications
Intramuscular route of active treatment, Intravenous route of active treatment - Status Epilepticus
Phase 3CompletedRobert Silbergleit10232009-06-012016-06-17
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children
Lorazepam - Status Epilepticus, Seizures
Phase 3CompletedAll India Institute of Medical Sciences1402008-05-012009-05-05
Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)
lorazepam or diazepam - Status Epilepticus
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2592008-02-012012-12-18
Seizure Therapy With Intravenous Levetiracetam and Lorazepam
Levetiracetam 1 g IV + Lorazepam 2 mg IV, Placebo + Lorazepam 3 mg IV - Seizures
Phase 2 / Phase 3WithdrawnMassachusetts General Hospital2008-01-012012-11-01
Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia
IM olanzapine, IM haloperidol plus lorazepam - Schizophrenia, Schizoaffective Disorder
Phase 3CompletedNational Taiwan University Hospital672006-07-012014-09-15
Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.
Lorazepam - Status Epilepticus, Convulsions
Phase 3TerminatedKamuzu University of Health Sciences8002006-06-012012-07-10
Lorazepam Sedation for Critically Ill Children
Lorazepam, Midazolam, Lorazepam CI - Critical Illness
Phase 2 / Phase 3CompletedThe Emmes Company, LLC1792004-09-012023-03-20
Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus
diazepam, lorazepam - Status Epilepticus
Phase 3CompletedNational Institute of Neurological Disorders and Stroke (NINDS)2101995-11-012005-06-24

Conditions studied

Status Epilepticus (7)  ·  Seizures (6)  ·  Epilepsy (3)  ·  Psychomotor Agitation (2)  ·  Schizophrenia (2)  ·  Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Critical Illness (1)  ·  Delirium (1)  ·  Dementia (1)  ·  Depression (1)  ·  Epilepsia Partialis Continua (1)  ·  Epilepsy, Partial, Motor (1)  ·  Lung Neoplasms (1)  ·  Mental Disorders (1)

Sponsors

All India Institute of Medical Sciences (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Biocodex (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Hannover Medical School (1)  ·  Kamuzu University of Health Sciences (1)  ·  Lone Baandrup (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  National Taiwan University Hospital (1)  ·  Pfizer (1)  ·  Robert Silbergleit (1)  ·  Shahid Beheshti University of Medical Sciences (1)

Countries

United States (6)  ·  France (3)  ·  Canada (2)  ·  Brazil (1)  ·  Denmark (1)  ·  Germany (1)  ·  India (1)  ·  Iran (1)  ·  Japan (1)  ·  Malawi (1)  ·  Taiwan (1)

Top investigators

Daniel H Lowenstein, MD (1)  ·  Daniel Lowenstein (1)  ·  David Hui (1)  ·  Elizabeth Molyneux (1)  ·  Helge Frieling, Prof., MD (1)  ·  Ian R Carroll (1)  ·  James Chamberlain, MD (1)  ·  Jeffrey L Blumer, MD, PhD (1)  ·  Joshua N. Goldstein, MD, PhD (1)  ·  Lone Baandrup, MD, DMSc (1)  ·  Melissa Carran, MD (1)

Results publications

PMID 21275979, PMID 21967361, PMID 22144928, PMID 22335736, PMID 22506949, PMID 22950484, PMID 24001080, PMID 24756515, PMID 25734733, PMID 25791540, PMID 27993298, PMID 28781452, PMID 29238824, PMID 30135030, PMID 30821824, PMID 32029262, PMID 33692709, PMID 33728561, PMID 34238838, PMID 34546899, PMID 34820831, PMID 35971024, PMID 35987977, PMID 36448276, PMID 40742738

NIH funding

2017 (1), 2023 (1), U01NS056975 (1)